Roche cuts loose Tamiflu OTC rights, handing Sanofi the keys as the pharma giant doubles...

[cafead]

via Roche set out to make a better flu medicine than Tamiflu as that franchise was headed to a generic showdown. Now they’ll see just how well Xofluza stacks up against the mainstay drug after handing off over-the-counter rights in the US to Sanofi.

article source